An association study of the brain‐derived neurotrophic factor Val66Met polymorphism and amphetamine response

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

• Publication date

  2006-09-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/ajmg.b.30327PMID 16823800PMCID PMC2556402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic susceptibility to substance dependence

  2005cited by this paper
• Interindividual variation in anxiety response to amphetamine: Possible role for adenosine A2A receptor gene variants

  2005cited by this paper
• Dopamine Transporter Gene Associated with Diminished Subjective Response to Amphetamine

  2005cited by this paper
• The neuroscience of addiction

  2005cited by this paper
• Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan

  2005cited by this paper
• Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitations, and implications

  2004cited by this paper
• A Single Infusion of Brain-Derived Neurotrophic Factor into the Ventral Tegmental Area Induces Long-Lasting Potentiation of Cocaine Seeking after Withdrawal

  2004cited by this paper
• Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism.

  2004cited by this paper
• Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance

  2003cited by this paper
• The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

  2003cited by this paper
• Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder.

  2003cited by this paper
• Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine

  2003cited by this paper
• Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine.

  2003cited by this paper
• Reduced Behavioral Effects of Cocaine in Heterozygous Brain-Derived Neurotrophic Factor (BDNF) Knockout Mice

  2003cited by this paper
• Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment – an oligonucleotide microarray approach

  2003cited by this paper
• Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder.

  2003cited by this paper
• The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

  2002cited by this paper
• Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration.

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.

  2002cited by this paper
• Molecular basis of long-term plasticity underlying addiction

  2001cited by this paper
• Molecular basis of long-term plasticity underlying addiction

  2001cited by this paper
• Effects of dextroamphetamine on cognitive performance and cortical activation.

  2000cited by this paper
• Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor

  1999cited by this paper
• Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice

  1999cited by this paper
• Neuroscience of addiction.

  1998cited by this paper
• Role of Neurotrophins in Synapse Development and Plasticity

  1997cited by this paper
• Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases

  1996cited by this paper
• Testing the abuse liability of anxiolytic and hypnotic drugs in humans.

  1991cited by this paper
• Trophic factors and neuronal survival.

  1989cited by this paper
• Individual differences in the discriminative stimulus effects of d‐amphetamine in humans

  1989cited by this paper
• Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.

  1986cited by this paper
• SCL-90-R, Administration, Scoring, and Procedures Manual-II for the R(evised) Version and Other Instruments of the Psychopathology Rating Scale Series

  1983cited by this paper
• Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients.

  1982cited by this paper
• Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior.

  1977cited by this paper
• Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

  1971cited by this paper
• Profile of mood states

  1971cited by this paper
• The Michigan alcoholism screening test: the quest for a new diagnostic instrument.

  1971cited by this paper

• Exploring peripheral biomarkers in psychostimulant use: a systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.

  2024cites this paper
• Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research

  2020cites this paper
• Oxytocin prevents the increase of cocaine‐related responses produced by social defeat

  2019cites this paper
• MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens

  2017cites this paper
• Cocaine and Brain-Derived Neurotrophic Factor

  2016cites this paper
• Regulation of nucleus accumbens transcript levels in mice by early-life social stress and cocaine.

  2016cites this paper
• A review of pharmacogenetic studies of substance-related disorders.

  2015cites this paper
• BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.

  2015cites this paper
• The Physiology of BDNF and Its Relationship with ADHD

  2014cites this paper
• The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder

  2014cites this paper
• ADHD pharmacogenetics across the life cycle: New findings and perspectives

  2014cites this paper
• Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse.

  2014cites this paper
• Candidate Gene Studies of a Promising Intermediate Phenotype: Failure to Replicate

  2013cites this paper
• BDNF Overexpression in the Ventral Tegmental Area Prolongs Social Defeat Stress-induced Cross-Sensitization to Amphetamine and Increases ΔFosB Expression in Mesocorticolimbic Regions of Rats

  2013cites this paper
• Brain-derived Neurotrophic Factor Signaling in the Mesolimbic Dopamine System: Social Defeat Stress-induced Cross-sensitization to Psychostimulants and Escalation of Cocaine Intake

  2013cites this paper
• Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice.

  2013cites this paper
• Toxicity of amphetamines: an update

  2012cites this paper
• Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use.

  2012cites this paper
• Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)

  2012cites this paper
• Genetic factors modulating the response to stimulant drugs in humans.

  2012cites this paper
• COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation.

  2012cites this paper
• Toxicity of amphetamines: an update Marcia CarvalhoHelena CarmoVera Marisa CostaJoao Paulo Capela • Helena PontesFernando RemiaoFelix CarvalhoMaria de Lourdes Bastos

  2012cites this paper
• 19. Dopamine Dysregulation Syndrome

  2011cites this paper
• Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.

  2011cites this paper
• Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity.

  2011cites this paper
• Early life stress decreases hippocampal BDNF content and exacerbates recognition memory deficits induced by repeated D-amphetamine exposure.

  2011cites this paper
• brain-derivedneurotrophicfactorpolymorphism with the developmental course of symptoms of attention deficit and hyperactivity

  2011cites this paper
• Subjective effects to marijuana associated with marijuana use in community and clinical subjects.

  2010cites this paper
• Brain potential indices of novelty processing are associated with preference for amphetamine.

  2010cites this paper
• Interaction effects between COMT and BDNF polymorphisms on boredom susceptibility of sensation seeking traits.

  2010cites this paper
• Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population.

  2010cites this paper
• Mutational spectrum of CDKL5 in early‐onset encephalopathies: a study of a large collection of French patients and review of the literature

  2009cites this paper
• Development of a new genotyping assay for detection of the BDNF Val66Met polymorphism using melting-curve analysis.

  2009cites this paper
• Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine

  2009cites this paper
• Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.

  2009cites this paper
• BDNF, relative preference, and reward circuitry responses to emotional communication

  2009cites this paper
• How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion

  2009cites this paper
• Dopamine Dysregulation Syndrome

  2008cites this paper
• The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome

  2008cites this paper
• Genetic Association of Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) With Alzheimer's Disease

  2008cites this paper
• Current awareness in human psychopharmacology

  2007cites this paper